R

RAPT Therapeutics
D

RAPT

35.390
USD
1.28
(3.75%)
مفتوح الان
حجم التداول
8,622
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
982,073,268
أصول ذات صلة الأخبار المقالات

العنوان: RAPT Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cellsinto inflamed tissues.